4.7 Article

Genetic dissection of SLE:: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 196, Issue 3, Pages 281-292

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20010955

Keywords

lupus; genetics; apoptosis; ALPS; anti-DNA

Funding

  1. NIAID NIH HHS [AI47460, R01 AI047460] Funding Source: Medline
  2. NIAMS NIH HHS [R01 AR044894, AR44894] Funding Source: Medline

Ask authors/readers for more resources

Genetic dissection of lupus pathogenesis in the NZM2410 strain has recently revealed that Sle1 is a potent locus that triggers the formation of IgG anti-histone/DNA antibodies, when expressed on the B6 background as a congenic interval. B6.lpr mice, in contrast, exhibit distinctly different cellular and serological phenotypes. Both strains, however, do not usually exhibit pathogenic autoantibodies, or succumb to lupus nephritis. In this study, we show that the epistatic interaction of Sle1 (in particular, Sle1/Sle1) with FAS(lpr) leads to massive lymphosplenomegaly (with elevated numbers of activated CD4 T cells, CD4(-)CD8(-) double negative (DN) T cells, and B1a cells), high levels of IgG and IgM antinuclear (including anti-ssDNA, anti-dsDNA, and anti-histone/DNA), and antiglomerular autoantibodies, histological, and clinical evidence of glomerulonephritis, and >80% mortality by 5-6 rno of age. Whereas FAS(lpr) functions as a recessive gene, Sle1 exhibits a gene dosage effect. These studies indicate that Slel and FAS(lpr), must be impacting alternate pathways leading to lymphoproliferative autoimmunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available